Burgess C D, Flatt A, Siebers R, Crane J, Beasley R, Purdie G
Department of Medicine, Wellington School of Medicine, Wellington Hospital, New Zealand.
Eur J Clin Pharmacol. 1989;36(4):415-7. doi: 10.1007/BF00558306.
The hypokalaemic effects of equal doses (5 mg) of fenoterol, salbutamol, terbutaline and an equal volume of saline administered by nebulization were compared in eight healthy subjects. Plasma potassium was measured at 15-min intervals for 60 min and at 90 min, 2, 4 and 6 h following administration. Fenoterol, salbutamol and terbutaline all significantly decreased plasma potassium when compared to saline; however, the magnitude and duration of this effect differed between the active agents. Both fenoterol and terbutaline significantly reduced plasma potassium for 4 h whereas salbutamol was only different from 30 to 120 min. The maximum decrease occurred with fenoterol (-0.78 mmol/l), followed by terbutaline (-0.70 mmol/l) and salbutamol (-0.33 mmol/l). Both terbutaline and fenoterol had a significantly greater effect compared with salbutamol. When administered by nebulization fenoterol and terbutaline are likely to have a greater hypokalaemic effect than salbutamol and this effect is likely to be more long lasting.
在8名健康受试者中比较了雾化吸入等剂量(5毫克)的非诺特罗、沙丁胺醇、特布他林以及等体积生理盐水的低钾血症效应。给药后,每隔15分钟测量血浆钾浓度,持续60分钟,并在90分钟、2小时、4小时和6小时测量。与生理盐水相比,非诺特罗、沙丁胺醇和特布他林均显著降低了血浆钾浓度;然而,不同活性药物的这种效应的程度和持续时间有所不同。非诺特罗和特布他林均在4小时内显著降低血浆钾浓度,而沙丁胺醇仅在30至120分钟内与生理盐水有差异。最大降幅出现在非诺特罗组(-0.78毫摩尔/升),其次是特布他林组(-0.70毫摩尔/升)和沙丁胺醇组(-0.33毫摩尔/升)。特布他林和非诺特罗的效应均显著大于沙丁胺醇。雾化吸入时,非诺特罗和特布他林可能比沙丁胺醇具有更强的低钾血症效应,且这种效应可能更持久。